6 search results for: epidemiology

expert video

Overview of Prurigo Nodularis Part 1: Clinical Features, Epidemiology, and Diagnosis

9 min

Dermatology

Discover key components of prurigo nodularis, including disease features, epidemiology, and practical considerations for diagnosis with Dr. Matt Zirwas in the first part of this discussion.

<b>Epidemiology</b> and Pathophysiology of AD in Children

expert video

Epidemiology and Pathophysiology of AD in Children

2 min

Dermatology

In this expert interview video focusing on topics from the October 2024 ADVENT symposium at EAPS in Vienna, Austria, Dr Christine Bangert discusses the epidemiology of AD in children and the role of type 2 cytokines in driving the pathophysiology of the disease

Podcast

ADVENT On Air | Getting to Grips With Atopic Hand and Foot Dermatitis: What Is It, and What Does It Mean for Patients?

20 min

Dermatology

This podcast episode looks at the epidemiology, clinical presentation and classification of atopic dermatitis of the hand and feet and the impact it has on patients' quality of life.

Infographic

The Patient Burden of Chronic Pruritus of Unknown Origin (CPUO)

5 min

Dermatology

An infographic describing the etiology, epidemiology, challenges in diagnosis and patient burden of CPUO.

expert video

Clinical Assessment of Prurigo Nodularis

9 min

Dermatology

Join Dr. Nicholas Mollanazar as he discusses the diagnosis and assessment of prurigo nodularis.

expert video

Heterogeneous Clinical Presentations and Diagnostic Challenges With Bullous Pemphigoid (BP)

10 min

Dermatology

Join Dr. Teri Greiling as she discusses the heterogeneous clinical presentations seen in bullous pemphigoid (BP). She also shares diagnostic challenges, including the unclear epidemiology and the extensive differential diagnoses faced by patients with BP.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region